dificid fidaxomicin 200 mg tablets in bottles
merck sharp & dohme (australia) pty ltd - fidaxomicin, quantity: 200 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; hyprolose; butylated hydroxytoluene; sodium starch glycollate; magnesium stearate; pregelatinised maize starch; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350; lecithin - dificid (fidaxomicin) is indicated for the treatment of confirmed clostridium difficile infection (cdi) in adults.
dificid- fidaxomicin tablet, film coated dificid- fidaxomicin granule, for suspension
merck sharp & dohme llc - fidaxomicin (unii: z5n076g8yq) (fidaxomicin - unii:z5n076g8yq) - fidaxomicin 200 mg - dificid® is indicated in adult and pediatric patients aged 6 months and older for the treatment of c. difficile -associated diarrhea (cdad). to reduce the development of drug-resistant bacteria and maintain the effectiveness of dificid and other antibacterial drugs, dificid should be used only to treat infections that are proven or strongly suspected to be caused by c. difficile . when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. dificid is contraindicated in patients who have known hypersensitivity to fidaxomicin or any other ingredient in dificid [see warnings and precautions (5.1)] . risk summary the limited available data on use of dificid in pregnant women are insufficient to inform any drug-associated risk for major birth defects, miscarriage or adverse maternal or fetal outcomes. embryo-fetal
dificid fidaxomicin 200 mg tablet blister pack
merck sharp & dohme (australia) pty ltd - fidaxomicin -
dificid fidaxomicin tablet film coated
avera mckennan hospital - fidaxomicin (unii: z5n076g8yq) (fidaxomicin - unii:z5n076g8yq) - fidaxomicin 200 mg
dificlir
tradis gat ltd - fidaxomicin - film coated tablets - fidaxomicin 200 mg - fidaxomicin - dificlir is indicated for the treatment of clostridium difficile infections (cdi) also known as c. difficile associated diarrhoea (cdad) in adult and paediatric patients aged 6 years and older.
fidaxomicin 40mg/ml oral suspension sugar free
tillotts pharma uk ltd - fidaxomicin - oral suspension - 40mg/1ml
dificlir
tillotts pharma gmbh - fidaxomicin - clostridium infections - antidiarrheals, intestinal antiinflammatory / antiinfective agents - dificlir film-coated tablets is indicated for the treatment of clostridioides difficile infections (cdi) also known as c. difficile-associated diarrhoea (cdad) in adult and paediatric patients with a body weight of at least 12.5 kg.consideration should be given to official guidelines on the appropriate use of antibacterial agents.dificlir granules for oral suspension is indicated for the treatment of clostridioides difficile infections (cdi) also known as c. difficile-associated diarrhoea (cdad) in adults and paediatric patients from birth to < 18 years of age.consideration should be given to official guidelines on the appropriate use of antibacterial agents.
dificid tablet
merck canada inc - fidaxomicin - tablet - 200mg - fidaxomicin 200mg - other macrolides
dificlir 200mg tablets
astellas pharma ltd - fidaxomicin - tablet - 200mg
daptomicina accord 350 mg 1 vial 10 ml solució perfussió